Fujirebio

The innovation engine powering global diagnostics

For 75 years, Fujirebio has been the innovation engine behind diagnostic breakthroughs that reach patients worldwide. While our name might not always be visible, our in vitro diagnostics (IVD) technology powers critical tests across the globe’s leading diagnostic platforms.

We are a biomarker and diagnostic content provider that strengthens diagnostics for everyone. Through our approach of innovation, clinical evidence and global CDMO partnerships, we ensure that next-generation biomarkers are accessible across diagnostic platforms, so patients benefit no matter which system is used.

For more information about Fujirebio please visit www.fujirebio.com.

We have a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states. Our IVD product lines span the range from specialized manual and automated testing to fully automated routine clinical laboratory testing solutions.